𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cloning and expression of a novel component of the CAP superfamily enhanced in the inflammatory response to LPS of the ascidianCiona intestinalis

✍ Scribed by Angela Bonura; Aiti Vizzini; Giuseppina Salerno; Daniela Parrinello; Nicolò Parrinello; Valeria Longo; Giovanna Montana; Paolo Colombo

Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
454 KB
Volume
342
Category
Article
ISSN
0302-766X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The efficacy of a novel, dual PI3K/mTOR
The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer
✍ Niranjan Awasthi; Peter L. Yen; Margaret A. Schwarz; Roderich E. Schwarz 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB

## Abstract Gemcitabine has limited clinical benefits for pancreatic ductal adenocarcinoma (PDAC). The phosphatidylinositol‐3‐kinase (PI3K)/AKT and mammalian target of rapamycin (mTOR) signaling pathways are frequently dysregulated in PDAC. We investigated the effects of NVP‐BEZ235, a novel dual PI

Heterogeneity in the angiogenic response
Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: Assessment by voxel analysis of dynamic contrast-enhanced MRI
✍ Ka-Loh Li; Lisa J. Wilmes; Roland G. Henry; Maria G. Pallavicini; John W. Park; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 783 KB

## Abstract ## Purpose To investigate the heterogeneity in the angiogenic response of a human breast cancer xenograft to a novel vascular endothelial growth factor (VEGF)‐receptor tyrosine kinase inhibitor, AG‐013736, using dynamic contrast‐enhanced MR imaging (DCE‐MRI). ## Materials and Methods